This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Malignant neoplasm of floor of mouth입바닥의 악성신생물 (구저암)

Contents and key points
ItemDetails
A. Classification codesICD-10: C04 | Special Copayment Reduction: V193 (copayment 5% for care for this diagnosis for 5 years from the date of cancer patient registration)
B. SynonymsFloor of mouth cancer, cancer of the floor of the oral cavity, mouth floor cancer; Floor of mouth carcinoma, Floor of mouth squamous cell carcinoma (SCCFOM), Sublingual carcinoma
C. Adult onsetLikelihood of first onset in adulthood very high — mostly diagnosed in the 50s–70s, with male predominance
1. HistorySystematized in the 19th century with the development of oral cancer surgery, introduction of radiation and brachytherapy in the 20th century, standardization of IMRT and free flap reconstruction in the 21st century
2. CausesSmoking (key), alcohol, poor oral hygiene, betel nut, immunosuppression, systemic malnutrition
3. GeneticsTP53·CDKN2A·FAT1·NOTCH1·PIK3CA mutations, EGFR overexpression, research on floor-of-mouth-specific molecular markers
4. General epidemiology10–15% of all oral cancers, male predominance (3–4:1), concentrated in the 50s–70s, high incidence in populations with heavy smoking and alcohol exposure
5. PathophysiologyPremalignant lesions of nonkeratinized mucosa → invasive carcinogenesis, early invasion of adjacent structures (mandible, tongue, salivary ducts), hyperactivation of the EGFR and PI3K pathways
6. SymptomsEarly: painless ulcer or swelling on the underside of the tongue; advanced: odynophagia, dysarthria, limited tongue movement, increased saliva, neck mass
7. SignsUlcerative mass of the floor of the mouth, fixation of the underside of the tongue, mandibular invasion, Wharton duct obstruction, cervical lymphadenopathy (levels I·II)
8. ScreeningOral visual examination (inspection of the floor of the mouth with the tongue raised), regular dental checkups, intensive surveillance of high-risk groups
9. DiagnosisCT·MRI·PET-CT, tissue biopsy, AJCC 8th edition TNM staging, evaluation of bone invasion and salivary duct invasion
10. TreatmentSurgery (wide excision+neck dissection+mandibular reconstruction), adjuvant IMRT, concurrent chemoradiotherapy, immunotherapy (pembrolizumab, nivolumab)
11. Prognosis5-year overall survival less than 40% (advanced stage); lymph node metastasis reduces survival by more than 50%, and cervical lymph node density is an independent prognostic factor
12. PreventionSmoking cessation and reduced alcohol (top priority), oral hygiene, regular dental and otolaryngology checkups, HPV vaccine, early management of premalignant lesions
13. ReferencesA nomogram for predicting overall survival of patients with squamous cell carcinoma of the floor of the mouth (Springer, 2023) ... and 9 other papers

1. History

Malignant tumors of the floor of the mouth are the most common site of oral malignant neoplasms after tongue cancer, and their treatment paradigm has historically changed with advances in surgery and radiation therapy. The floor of the mouth is the space between the ventral surface of the tongue, the inner surface of the mandible, and the mylohyoid muscle, and has an anatomically complex structure with the parotid duct and the mylohyoid nerve adjacent to it.

Early records of floor of mouth cancer can be found in 19th-century European surgery. At that time, wide excision including the mandible was performed, but without reconstruction, severe functional impairment was unavoidable. After the introduction of X-ray radiation therapy in the early 20th century, radiation alone or combined with surgery began to be applied to floor of mouth cancer. In the 1950s–1970s, interstitial brachytherapy (insertion of iridium-192 wire) became established as an effective treatment for early floor of mouth cancer and was widely used, particularly in Europe.

In the 1980s–1990s, the development of microvascular free flap reconstruction made functional reconstruction possible after wide excision of the floor of the mouth. The radial forearm free flap emerged as the standard procedure for floor of mouth reconstruction. Since the 2000s, the introduction of IMRT has improved the precision of adjuvant radiation and contributed to preserving salivary gland function and reducing side effects. In the 21st century, the introduction of immunotherapy has expanded treatment options for recurrent and metastatic floor of mouth cancer.

In Korea, multidisciplinary collaboration among oral and maxillofacial surgery, otolaryngology-head and neck surgery, radiation oncology, and plastic surgery has become the standard for treating floor of mouth cancer, and systematic MDT clinics are run at the National Cancer Center and major tertiary medical institutions.


2. Causes

The risk factors for floor of mouth cancer are similar to those of other oral cancers, with smoking and alcohol being the strongest risk factors. The floor of the mouth is where saliva flow collects, an anatomical characteristic that makes it easy for carcinogens from tobacco smoke and alcohol to remain in contact with this area for long periods.

Smoking

Carcinogens in tobacco smoke (PAHs, nitrosamines, benzopyrene) act directly on the non-keratinized epithelium of the floor of the mouth mucosa, causing DNA damage. The risk of floor of mouth cancer increases in proportion to smoking amount and duration, and pipe smoking is also a risk factor. After quitting smoking, the risk gradually decreases.

Alcohol

The direct toxicity of acetaldehyde, a metabolite of ethanol, and its effect of increasing mucosal permeability contribute to carcinogenesis. The more alcohol consumed, the higher the risk, and combined exposure to smoking and alcohol produces a synergistic increase in risk. Drinking 3 or more drinks a day raises the risk of floor of mouth cancer to about 2–3 times that of nondrinkers.

Poor oral hygiene and other factors

Poor oral hygiene and chronic oral infection are also supplementary risk factors. Betel nut (areca) chewing is an important risk factor in Southeast and South Asia. Immunosuppression (organ transplantation, HIV infection), nutritional deficiencies (vitamins A, C, E, iron), and a history of radiation exposure also increase the risk. HPV-related floor of mouth cancer is rare (about 5%) but is found in some patients.


3. Genetics

The molecular genetics of floor of mouth cancer follows the general mutation pattern of oral squamous cell carcinoma; most are of the HPV-negative subtype, and the main mechanism is accumulation of mutations from smoking and alcohol.

Major somatic mutations

TP53 mutations (about 50–70%) are the most common. CDKN2A (p16) deletion or hypermethylation causes escape from cell cycle control. Loss-of-function mutations of FAT1 (Wnt pathway regulation) and NOTCH1 contribute to inhibition of cell differentiation. Activating mutations of PIK3CA hyperactivate the PI3K/AKT/mTOR pathway. CASP8 mutations confer resistance to apoptosis and contribute to treatment resistance.

EGFR overexpression and targeted therapy

EGFR is overexpressed in 80–90% of oral squamous cell carcinomas, including floor of mouth cancer. EGFR overexpression correlates with a poor prognosis and is the molecular basis for the use of cetuximab (an EGFR monoclonal antibody). PD-L1 CPS is used to determine eligibility for first-line pembrolizumab treatment.

Hereditary syndromes

Patients with Fanconi anemia have a markedly increased risk of head and neck squamous cell carcinoma, including oral cancer, due to defective DNA repair. Li-Fraumeni syndrome (TP53 germline variants) and Bloom syndrome are also associated with increased oral cancer risk.


4. General epidemiology

Floor of mouth cancer is a relatively uncommon oral cancer, accounting for about 10–15% of all oral squamous cell carcinomas, but it is clinically important because of its high risk of cervical lymph node metastasis and poor prognosis.

Global and Korean incidence

Oral cancer (excluding the lip) occurs in about 389,000 cases annually worldwide, of which floor of mouth cancer accounts for about 10–15%. In Europe and North America, incidence tends to have stabilized somewhat along with declining smoking rates, but some Eastern European and South Asian countries still show high incidence. In Korea, separate incidence statistics for floor of mouth cancer are limited, but in the site distribution of head and neck squamous cell carcinoma it is a major site along with tongue cancer and gingival cancer.

Sex and age distribution

Floor of mouth cancer has an incidence about 3–4 times higher in men than in women, reflecting sex differences in smoking and alcohol use. The main age of onset is the 50s–70s, and incidence increases with age. Anterior floor of mouth cancer is common in men with smoking-related disease, and posterior floor of mouth cancer in older patients. The anterior type of floor of mouth cancer shows a stronger association with pN2-3 lymph node metastasis and multiple primary tumors.


5. Pathophysiology

Floor of mouth cancer arises from the non-keratinized squamous epithelium of the floor of the mouth and goes through a multistep carcinogenic process, progressing from normal mucosa through premalignant lesions to invasive cancer. Because of its nonkeratinized nature, the floor of the mouth is more vulnerable to carcinogens.

Premalignant lesions and dysplasia

Leukoplakia and erythroplakia of the floor of the mouth are the most important premalignant lesions. Erythroplakia of the floor of the mouth has a particularly high rate of malignant transformation (30–50%). As dysplasia progresses from mild to moderate to severe, TP53 and CDKN2A mutations accumulate. Abnormal DNA methylation and chromosomal instability due to chronic smoking and alcohol exposure are already observed at the premalignant stage.

Invasion of adjacent structures

Anatomically, the floor of the mouth is adjacent to the underside of the tongue, the inner surface of the mandible, the mylohyoid nerve, the mylohyoid muscle, and the digastric muscle. Floor of mouth cancer tends to invade the underside of the tongue and the cortical bone of the mandible early, and can cause submandibular gland dysfunction through obstruction of Wharton's duct. Perineural invasion (PNI) can spread via the lingual nerve and the mylohyoid nerve.

Major signaling pathways and the tumor microenvironment

Hyperactivation of the EGFR/RAS/MAPK and PI3K/AKT/mTOR pathways promotes cell proliferation, survival, and invasion. In the tumor microenvironment, immunosuppressive cells (Treg, MDSC) and cytokines (TGF-β, IL-10) weaken antitumor immunity.


6. Symptoms

Early symptoms of floor of mouth cancer are nonspecific, so delayed diagnosis is common. Because the floor of the mouth consists of nonkeratinized mucosa, it is sensitive to friction, and symptoms may be prominent even with early ulcers.

Early symptoms

The most common early symptom is a painless ulcer or swelling on the underside of the tongue. When the tongue is lifted, leukoplakic patches, erythroplakic changes, and irregular ulcers of the floor of the mouth are seen. A foreign body sensation in the mouth, mild pain, and changes in salivation (excess saliva or xerostomia) are also early presentations. Tumors near Wharton's duct can cause swelling of the submandibular gland.

Advanced symptoms

When the tumor invades the underside of the tongue, limited tongue movement and dysarthria appear. With mandibular invasion, inferior alveolar nerve palsy causes numbness and paresthesia of the lower lip and chin. Odynophagia and dysphagia progress, and oral bleeding may accompany them. With pterygoid muscle invasion, trismus appears. In some cases, a neck mass due to cervical lymph node metastasis is the first symptom.

Systemic symptoms

In advanced cancer, weight loss, loss of appetite, generalized fatigue, and malnutrition accompany the disease.


7. Signs

Findings on oral inspection

When the tongue is lifted anteriorly and superiorly, the tumor of the floor of the mouth is seen. It appears as an ulcerative lesion with irregular margins or an exophytic mass, with bleeding, necrosis, or keratinized tissue on the surface. Bimanual palpation is used to evaluate the depth of the tumor and mandibular invasion. Ductal invasion is checked by observing the Wharton duct orifices (on both sides of the frenulum).

Neck findings

Floor of mouth cancer has a very high rate of cervical lymph node metastasis, with a positive neck found in about 40–50% at the first visit. It metastasizes mainly to ipsilateral level I·II·III lymph nodes, and bilateral metastasis is common in anterior floor of mouth cancer. The lymph nodes around the internal jugular vein (jugulodigastric node) are involved first.

Neurological findings

With invasion of the lingual nerve (a branch of CN V3), decreased sensation or numbness of the anterior 2/3 of the tongue appears. With invasion of the mylohyoid nerve, sensory abnormalities of the floor of the mouth accompany it. With invasion of the inferior alveolar nerve (CN V3), numbness of the lower lip and chin (Vincent sign) appears.


8. Screening

Because the floor of the mouth can be inspected when the tongue is raised, a properly performed oral visual examination is the key to early detection.

Technique of oral visual examination

Instruct the patient to lift the tongue upward and inspect the entire floor of the mouth (anterior, lateral, posterior). Use a tongue depressor and light to observe the lateral and posterior floor of the mouth. Systematically inspect the entire floor of mouth mucosa, including the floor of mouth mucosa on both sides of the lingual frenulum on the underside of the tongue.

Regular dental and otolaryngology checkups

Inspection of the floor of the mouth must be included in regular dental checkups. The condition of the floor of mouth mucosa is also evaluated in otolaryngology examinations. Men who smoke and drink, betel nut users, and patients with premalignant lesions need intensive surveillance at 3–6 month intervals.

Management of premalignant lesions

When leukoplakia or erythroplakia of the floor of the mouth is found, immediate biopsy and grading of dysplasia are needed. Moderate or more severe dysplasia is treated with surgical excision or laser ablation and reassessed at 3-month intervals.


9. Diagnosis

Imaging

CT (contrast-enhanced, including the jaw): evaluates tumor size and location, invasion of the mandibular cortical bone, and cervical lymph node metastasis. Invasion of the mylohyoid nerve and deep structures is also checked. MRI (T1, T2, contrast-enhanced): excellent for evaluating the extent of soft tissue invasion (extrinsic tongue muscles, sublingual space, mylohyoid muscle), perineural invasion, and invasion of the mandibular medullary cavity. PET-CT: used to search for distant metastasis and heterotopic primary tumors.

Tissue biopsy and pathology

About 90% or more of floor of mouth cancers are squamous cell carcinoma, and the degree of differentiation (well/moderately/poorly differentiated) affects prognosis. Adenoid cystic carcinoma of minor salivary gland origin and others are also included in the differential diagnosis. The pathology report must include depth of invasion (DOI), perineural invasion, lymphovascular invasion, and resection margins.

TNM staging (AJCC 8th edition)

The T classification of floor of mouth cancer applies the same criteria as tongue cancer (tumor size, including DOI). Because anterior floor of mouth cancer has a high risk of bilateral neck metastasis, both sides of the neck must be evaluated for N classification. The indication for elective neck dissection is DOI >4 mm or a clinically positive neck.


10. Treatment

For floor of mouth cancer, surgery is the first-line standard treatment, and surgical strategies show better oncologic outcomes than radiation therapy alone.

Surgery

Wide excision: resection of the floor of the mouth including the tumor and an adequate resection margin (at least 5 mm) is performed. If there is no invasion of the mandibular cortical bone, marginal mandibulectomy is performed, and if there is medullary invasion, segmental mandibulectomy. With invasion of the underside of the tongue, partial glossectomy is performed together. Anterior floor of mouth cancer requires bilateral neck dissection (level I-III). Microvascular free flap reconstruction: the radial forearm free flap (RFFF) is the standard for floor of mouth reconstruction, and when mandibular reconstruction is needed, a fibula free flap is used.

Adjuvant radiation and chemoradiotherapy

When there are high-risk pathological findings (positive margins, ENE, perineural invasion, pN2 or higher), adjuvant IMRT (60–66 Gy) or concurrent chemoradiotherapy with cisplatin is given.

Recurrent and metastatic floor of mouth cancer

Based on KEYNOTE-048, pembrolizumab monotherapy (CPS≥1) or pembrolizumab combination therapy is used as first-line treatment. Based on CheckMate 141, nivolumab is used as second-line treatment. Cetuximab+EXTREME combination is also a first-line treatment option.


11. Prognosis

Floor of mouth cancer is a subtype of oral cancer with a relatively poor prognosis, because of its high rate of cervical lymph node metastasis and early invasion of adjacent structures.

Survival by stage

Stage5-year overall survival rateKey characteristics
Stage I-IIAbout 60–75%Early resection possible, neck negative
Stage IIIAbout 35–50%Neck positive, adjuvant treatment needed
Stage IVLess than about 20–40%Extensive invasion, combined treatment
Overall averageLess than about 40%High proportion found at an advanced stage

Impact of lymph node metastasis

When cervical lymph node metastasis is present, survival decreases by more than 50% compared with when it is absent. The higher the lymph node density (number of metastatic lymph nodes/number of lymph nodes examined), the poorer the prognosis, and it has been reported as an independent prognostic factor. Extranodal extension (ENE) is one of the strongest poor prognostic factors. pN2-3 metastasis is more common in the anterior type of floor of mouth cancer than in the posterior type.

Functional prognosis

After floor of mouth reconstruction, recovery of swallowing, speech, and chewing function has a decisive effect on quality of life. After radiation therapy, xerostomia, dysphagia, and oral fibrosis may occur as long-term complications. Early involvement of the rehabilitation medicine and speech therapy teams is essential for improving functional outcomes.


12. Prevention

Primary prevention

Smoking cessation is the most effective single intervention for preventing floor of mouth cancer. By blocking direct contact between tobacco smoke and the floor of mouth mucosa, it markedly reduces carcinogen exposure. Reducing alcohol: limiting alcohol intake (2 units or less per day for men) reduces the risk of floor of mouth cancer, and combined with smoking cessation the risk reduction is doubled. Maintaining oral hygiene: chronic irritation is minimized through regular dental checkups (at least once a year), scaling, and removal of residual roots and ill-fitting prostheses. HPV vaccine: the 9-valent HPV vaccine contributes to preventing HPV-related oral cancer, but its direct effect on floor of mouth cancer is limited.

Secondary prevention

Premalignant lesions are detected early through oral self-examination with the tongue raised and regular dental and otolaryngology checkups. When erythroplakia or leukoplakia of the floor of the mouth is found, immediate biopsy is needed. In high-risk groups who smoke and drink, intensive follow-up at 3–6 month intervals is recommended.

Chemoprevention

Retinoids and COX-2 inhibitors have been studied for chemoprevention of oral premalignant lesions, but have not been established as a clinical standard.


13. References

  1. Ettl T, Schwarz-Furlan S, Gosau M, Reichert TE. A nomogram for predicting overall survival of patients with squamous cell carcinoma of the floor of the mouth. European Archives of Oto-Rhino-Laryngology. 2023;280:3987-3996. DOI: 10.1007/s00405-023-07971-5

  2. Burtness B, Harrington KJ, Greil R, et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048). The Lancet. 2019;394(10212):1915-1928. DOI: 10.1016/S0140-6736(19)32591-7

  3. Ferris RL, Blumenschein G Jr, Fayette J, et al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck (CheckMate 141). New England Journal of Medicine. 2016;375(19):1856-1867. DOI: 10.1056/NEJMoa1602252

  4. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers. Version 1.2026. NCCN. 2025. Available at: https://www.nccn.org

  5. Amin MB, Edge S, Greene F, et al. (eds). AJCC Cancer Staging Manual, 8th Edition. Springer. 2017. ISBN: 978-3-319-40617-6.

  6. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022. CA: A Cancer Journal for Clinicians. 2024;74(3):229-263. DOI: 10.3322/caac.21834

  7. Comparison of Clinicopathological Characteristics Between the Anterior and Posterior Type of Squamous Cell Carcinoma of the Floor of the Mouth. Cancers (Basel). 2021;13(13):3201. DOI: 10.3390/cancers13133201

  8. Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer. Journal of Clinical Oncology. 2017;35(31):3601-3609. DOI: 10.1200/JCO.2016.71.1176

  9. D'Cruz AK, Vaish R, Kapre N, et al. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. New England Journal of Medicine. 2015;373(6):521-529. DOI: 10.1056/NEJMoa1506007

  10. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians. 2023;73(1):17-48. DOI: 10.3322/caac.21763